Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Acuvi AB is a prominent player in the precision technology industry, specializing in the development and production of advanced optical and opto-mechanical solutions. Known for its innovation, Acuvi AB serves a variety of sectors, including telecommunications, medical technology, and industrial automation, by offering tailored components that enhance precision and operational efficiency in cutting-edge applications. Its products are integral to the accuracy and performance of optical systems, making them critical in environments where exacting standards and reliability are paramount. Operating from its headquarters in Sweden, Acuvi AB not only influences industries by providing high-quality solutions but also contributes to technological advancements that drive these sectors forward. The company's role in the financial market is underscored by its ability to foster industry growth through continuous innovation and by meeting the evolving demands of its global client base.
kr 1.02
kr 0.00 (-0.19%)
EOD Jun 23, 2026 · Twelve Data
The business is unprofitable at the operating level (-2.07% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 16.1%, still solid. Margins contracted 13.0pp, which offsets some of the top-line progress.
ROIC dropped from 4.69% to -0.69%, capital efficiency is deteriorating. Negative free cash flow of -kr 19M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
kr 204M
▲ +16.1% YoY
Net Income (TTM)
-kr 28M
▼ -153.5% YoY
Op. Margin
-9.05%
▼ -13.0pp YoY
ROIC
-0.69%
▼ -5.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-kr 13M
▼ -106.9% YoY
Op. Cash Flow (TTM)
-kr 7M
▼ -636.2% YoY
Net Debt
kr 43M
Cash & Equiv.
kr 17M
3Y CAGR: +3.3%
Continue Research
Acuvi AB (ACUVI.XSTO)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Acuvi AB scores 23/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Acuvi AB scores 23 out of 100 on Intrinsiqq's quality score, passing 1 of 6 checks, which makes it a lower-quality business on these measures. Recent fundamentals include a -9.1% operating margin and a -0.7% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full check-by-check breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh ACUVI.XSTO's valuation and scores 23/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.